Aedes aegypti salivary protein "aegyptin" co-inoculation modulates dengue virus infection in the vertebrate host

Document Type

Journal Article

Publication Date

1-1-2014

Journal

Virology

Volume

468-470

DOI

10.1016/j.virol.2014.07.019

Keywords

Aegyptin; Allergen; Dengue; Mosquito; Mouse; Saliva; Virus

Abstract

Dengue virus (DENV) is transmitted in the saliva of the mosquito vector Aedes aegypti during blood meal acquisition. This saliva is composed of numerous proteins with the capacity to disrupt hemostasis or modulate the vertebrate immune response. One such protein, termed "aegyptin," is an allergen and inhibitor of clot formation, and has been found in decreased abundance in the saliva of DENV-infected mosquitoes. To examine the influence of aegyptin on DENV infection of the vertebrate, we inoculated IRF-3/7-/- -/- mice with DENV serotype 2 strain 1232 with and without co-inoculation of aegyptin. Mice that received aegyptin exhibited decreased DENV titers in inoculation sites and in circulation, as well as increased concentrations of GM-CSF, IFN-γ, IL-5, and IL-6, at 48h post-inoculation when compared to mice that received inoculation of DENV alone. These and other data suggest that aegyptin impacts DENV perpetuation via elevated induction of the immune response. © 2014 Elsevier Inc.

Link to Full Text

Share

COinS